JPMorgan Chase & Co’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Buy |
30,420
+25,681
| +542% | +$103K | ﹤0.01% | 4712 |
|
|
2025
Q1 | $15.1K | Sell |
4,739
-19,716
| -81% | -$62.7K | ﹤0.01% | 5355 |
|
|
2024
Q4 | $131K | Sell |
24,455
-25,101
| -51% | -$134K | ﹤0.01% | 4682 |
|
|
2024
Q3 | $262K | Buy |
49,556
+40,404
| +441% | +$213K | ﹤0.01% | 4356 |
|
|
2024
Q2 | $16.7K | Sell |
9,152
-43,672
| -83% | -$79.5K | ﹤0.01% | 5181 |
|
|
2024
Q1 | $94K | Buy |
52,824
+52,145
| +7,680% | +$92.8K | ﹤0.01% | 4757 |
|
|
2023
Q4 | $1.2K | Sell |
679
-69,228
| -99% | -$122K | ﹤0.01% | 5771 |
|
|
2023
Q3 | $102K | Buy |
69,907
+68,706
| +5,721% | +$100K | ﹤0.01% | 4590 |
|
|
2023
Q2 | $2.75K | Hold |
1,201
| – | – | ﹤0.01% | 5385 |
|
|
2023
Q1 | $1K | Hold |
1,201
| – | – | ﹤0.01% | 5637 |
|
|
2022
Q4 | $1K | Sell |
1,201
-1,585
| -57% | -$1.32K | ﹤0.01% | 5435 |
|
|
2022
Q3 | $2K | Buy |
2,786
+818
| +42% | +$587 | ﹤0.01% | 5320 |
|
|
2022
Q2 | $2K | Sell |
1,968
-3,531
| -64% | -$3.59K | ﹤0.01% | 5407 |
|
|
2022
Q1 | $9K | Buy |
5,499
+1,396
| +34% | +$2.29K | ﹤0.01% | 5403 |
|
|
2021
Q4 | $10K | Buy |
+4,103
| New | +$10K | ﹤0.01% | 5433 |
|
|
2019
Q3 | – | Sell |
-66,687
| Closed | -$226K | – | 4779 |
|
|
2019
Q2 | $226K | Sell |
66,687
-100,434
| -60% | -$340K | ﹤0.01% | 3723 |
|
|
2019
Q1 | $673K | Sell |
167,121
-62,171
| -27% | -$250K | ﹤0.01% | 3227 |
|
|
2018
Q4 | $841K | Buy |
229,292
+111,779
| +95% | +$410K | ﹤0.01% | 3134 |
|
|
2018
Q3 | $1.01M | Buy |
117,513
+2,997
| +3% | +$25.7K | ﹤0.01% | 3166 |
|
|
2018
Q2 | $1.26M | Sell |
114,516
-103,681
| -48% | -$1.14M | ﹤0.01% | 3030 |
|
|
2018
Q1 | $2.52M | Sell |
218,197
-27,264
| -11% | -$314K | ﹤0.01% | 2612 |
|
|
2017
Q4 | $2.54M | Sell |
245,461
-70,739
| -22% | -$733K | ﹤0.01% | 2620 |
|
|
2017
Q3 | $5.11M | Sell |
316,200
-16,434
| -5% | -$265K | ﹤0.01% | 2170 |
|
|
2017
Q2 | $4.03M | Buy |
332,634
+178,658
| +116% | +$2.16M | ﹤0.01% | 2241 |
|
|
2017
Q1 | $3.2M | Sell |
153,976
-26,123
| -15% | -$543K | ﹤0.01% | 2350 |
|
|
2016
Q4 | $2.58M | Buy |
180,099
+15,199
| +9% | +$217K | ﹤0.01% | 2526 |
|
|
2016
Q3 | $2.71M | Sell |
164,900
-10,200
| -6% | -$168K | ﹤0.01% | 2312 |
|
|
2016
Q2 | $2.5M | Buy |
+175,100
| New | +$2.5M | ﹤0.01% | 2351 |
|